И. И. Топчий
68 works · 1,015 citations · h-index 5
Top works
- Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial
- Effects of dapagliflozin on mortality in patients with chronic kidney disease: a pre-specified analysis from the DAPA-CKD randomized controlled trial
- A pre-specified analysis of the Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial on the incidence of abrupt declines in kidney function
- Effect of SGLT2 Inhibitors on Stroke and Atrial Fibrillation in Diabetic Kidney Disease
- Kidney and Cardiovascular Effects of Canagliflozin According to Age and Sex: A Post Hoc Analysis of the CREDENCE Randomized Clinical Trial
- INFLUENCE OF GLICEROL ON FUNCTIONAL-MORPHOLOGICAL INDICATORS OF KIDNEYS AT MODELLING RENAL INSUFFICIENCY IN RATS
- Serum Klotho protein level in type 2 diabetic patients depending on the renal function
- [ASSOCIATION OF FIBROBLAST GROWTH FACTOR 23 WITH MARKERS OF INFLAMMATION AND FIBROSIS IN DIABETIC NEPHROPATHY].
- Left Ventricle Structural and Functional Peculiarities in Patients with Diabetic Nephropathy
- EFFECT OF CRYO PLACENTA EXTRACT ON THE STRUCTURE AND FUNCTION OF KIDNEYS RATS WITH ACUTE OR CHRONIC RENAL FAILURE
- Morphological features of structure of aorta, coronal arteries and myocardium at chronic kidneys disease
- RELATIONSHIP OF THE CONDITION OF THE MYOCARDIUM WITH INFRINGEMENTS THE CALCIUM AND PHOSPHORUS METABOLISM INPATIENTS WITH DIABETIC NEPHROPATHY
- Features of development of diastolic heart dysfunction in patients with comorbid pathology depending on the functional state of the kidney
- MP425ASSOCIATION OF VISFATIN WITH INFLAMMATORY AND FIBROTIC MARKERS IN TYPE 2 DIABETIC PATIENTS WITH NEPHROPATHY
- Nephroprotective effect of dapagliflozin in type 2 diabetes mellitus: A potential role of Klotho protein
- Changes of the morphogenetic proteins FGF23 and Klotho increase risk of cardiovascular events
- FEATURES OF ENDOTHELIUM MORPHOLOGICAL STRUCTURE IN KIDNEY VESSELS, CORONARY ARTERIES AND AORTA DURING CHRONIC KIDNEY DISEASE
- ПЕРЕКИСНОЕ ОКИСЛЕНИЯ ЛИПИДОВ И МЕТАБОЛИЗМ ОКСИДА АЗОТА У БОЛЬНЫХ ХРОНИЧЕСКОЙ БОЛЕЗНЬЮ ПОЧЕК В ДИНАМИКЕ ЛЕЧЕНИЯ
- Генетичні особливості ремоделювання серця у хворих на діабетичну нефропатію
- Применение мельдония при лечении больных диабетической нефропатией